Aker BioMarine ASA (OSL:AKBM) ROCE % : -3.18% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aker BioMarine ASA's annualized ROCE % for the quarter that ended in Mar. 2024 was -3.18%.

Aker BioMarine ASA ROCE % Historical Data

The historical data trend for Aker BioMarine ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA ROCE % Chart

Aker BioMarine ASA Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-0.12

3.12

0.98

4.87

-0.07

Aker BioMarine ASA Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-5.46	3.44	5.86	-4.28	-3.18

Aker BioMarine ASA ROCE % Calculation

Aker BioMarine ASA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-5.275	/	( ( (8125.394 - 1034.446)	+	(8725.409 - 1191.027) )	/ 2 )
	=	-5.275	/	( (7090.948	+	7534.382)	/ 2 )
	=	-5.275	/	7312.665
	=	-0.07 %

Aker BioMarine ASA's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-237.712	/	( ( (8725.409 - 1191.027)	+	(8632.943 - 1204.473) )	/ 2 )
	=	-237.712	/	( ( 7534.382	+	7428.47 )	/ 2 )
	=	-237.712	/	7481.426
	=	-3.18 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Aker BioMarine ASA (OSL:AKBM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aker BioMarine ASA ROCE % Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aker BioMarine ASA (OSL:AKBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

1PG:Germany

Address

Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327

Website

https://www.akerbiomarine.com

Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines